Almac Clinical Technologies has announced the availability of Simplify, a next-generation interactive response technology (IRT) system that comes standard with an array of configurable functionality designed to accelerate the study startup process with greater efficiency.
Simplify was designed for trial sponsors and contract research organizations (CROs) that need to quickly and efficiently stand up critical eClinical infrastructure with minimal effort or oversight. The new IRT system offers a no-hassle, straightforward approach for deploying industry-leading IRT capabilities in half the time of traditional systems.
To provide faster implementation time with the same level of high quality, Almac conducted an extensive analysis of more than 3,000 clinical trials that the Almac IRT solutions previously supported for the purpose of identifying and standardizing the most commonly requested and critical IRT functions. As a result, Simplify offers trial sponsors and CROs a streamlined and consolidated deployment schedule that eliminates traditional bottlenecks typically associated with requirements gathering, customization specifications, and prolonged periods of user acceptance testing.
Simplify is powered by Almac IXRS 3 technology. “Simplify sets itself apart from other IRT alternatives by offering the flexibility to scale the scope of your solution to at any time,” explains Valarie Higgins, president and managing director of Almac Clinical Technologies. “This means that unplanned, or unexpected, protocol changes that require custom solutions can be swiftly implemented without requiring a major redesign, and are guided by our expert team of biostatistical, integration, design, and support consultants.”
In the current environment, where time is of the essence, Simplify has already demonstrated success through a recent collaboration with a Top 10 multinational pharmaceutical company that needed to deploy an expedited clinical trial in support of COVID-19. Together with Simplify and Almac Clinical Technologies, the trial sponsor was able to progress from award of the contract to patient enrollment in just seven days.